Form 4: Boston Scientific SVP Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, executed stock options and sold shares under a pre-established Rule 10b5-1 trading plan.
Summary
- On February 28, 2025, Emily Woodworth exercised stock options to acquire 7,218 shares of Boston Scientific common stock at a price of $42.16 per share.
- Simultaneously, Woodworth sold 9,887 shares of common stock at a price of $101.13 per share.
- On March 1, 2025, Woodworth also acquired 837 shares of common stock through the vesting of restricted stock units.
- Woodworth disposed of 355 shares to cover tax obligations at a price of $103.79.
- These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports routine insider trading activity under a pre-established plan. There is no indication of positive or negative sentiment towards the company's performance or future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but it outlines the ongoing vesting schedule for restricted stock units through March 1, 2028.
Industry Context
Form 4 filings are routine disclosures of insider transactions, providing transparency into the trading activities of company executives. These filings are closely watched by investors for signals about management's confidence in the company's prospects. The use of a 10b5-1 plan indicates that the transactions were pre-planned and not based on any material non-public information.
Comparison to Industry Standards
- Executive compensation packages in the medical device industry, including companies like Medtronic (MDT) and Abbott Laboratories (ABT), often include stock options and restricted stock units as part of their long-term incentive plans.
- The vesting schedules and exercise prices are generally aligned with industry norms to incentivize performance and retention.
- The use of 10b5-1 trading plans is a common practice among executives to avoid accusations of insider trading when selling company stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership of shares.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| February 18, 2021 | First anniversary of stock option grant, with vesting in four equal annual installments. |
| November 29, 2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| February 28, 2025 | Exercise of stock options and sale of common stock. |
| March 1, 2025 | Vesting of restricted stock units and disposal of shares for tax obligations. |
| March 1, 2025 | First anniversary of restricted stock unit grant, with shares issued in four equal annual installments. |
| 03/01/2028 | Expiration date of restricted stock units. |
| 02/18/2030 | Expiration date of stock options. |
| 03/03/2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.